Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC-Reference-Cited by-同舟云学术

Nucleolin aptamer conjugated MSNPs-PLR-PEG multifunctional nanoconstructs for targeted co-delivery of anticancer drug and siRNA to counter drug resistance in TNBC

Published:2023-02 Issue: Volume:229 Page:600-614
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Kumar Pramod,Salve Rajesh,Paknikar Kishore M.,Gajbhiye Virendra

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference71 articles.

1. Triple-negative breast cancer: disease entity or title of convenience?;Carey;Nat. Rev. Clin. Oncol.,2010

2. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry;Bauer;Cancer,2007

3. Update on triple-negative breast cancer: prognosis and management strategies;Brouckaert;Int. J. Women's Health,2012

4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J. Clin. Invest.,2011

5. The omics of triple-negative breast cancers;Xu;Clin. Chem.,2014

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of docetaxel against breast cancer;Journal of Drug Delivery Science and Technology;2024-09

2. Albumin‐Loaded Silica Nanomaterials Functionalized with Organotin(IV) Agents: Theranostic Materials Against Triple‐Negative Breast Cancer;Advanced Therapeutics;2024-07-11

3. Recent Progress of Multifunctional Molecular Probes for Triple-Negative Breast Cancer Theranostics;Pharmaceutics;2024-06-14

4. Stimuli‐Responsive Aptamer‐Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release;Advanced Healthcare Materials;2024-05-19

5. MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells;Frontiers in Bioengineering and Biotechnology;2024-04-18